NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allarity Therapeutics, Inc. ("Allarity" or "the Company") (NASDAQ:ALLR). Investors who purchased Allarity securities prior to May 17, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ALLR.

image for news Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/EXTR.

image for news Bronstein, Gewirtz & Grossman, LLC Encourages Extreme Networks, Inc. (EXTR) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Skyworks Solutions, Inc. ("Skyworks" or "the Company") (NASDAQ:SWKS). Investors who purchased Skyworks securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SWKS.

image for news Bronstein, Gewirtz & Grossman, LLC Is Investigating Skyworks Solutions, Inc. (SWKS) And Encourages Stockholders to Connect

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company") (NASDAQ:CRGX). Investors who purchased CARGO securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CRGX.

image for news Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Shareholders to Reach Out

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=128405&wire=1 or contact Joseph E. Levi, Esq.

image for news Investors who lost money on Grocery Outlet Holding Corp. (GO) should contact Levi & Korsinsky about pending Class Action - GO

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of e.l.f. Beauty, Inc. ("e.l.f.

image for news Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against e.l.f. Beauty, Inc. (ELF) and Encourages Stockholders to Learn More About the Investigation

Tesla's stock continues to pullback, as the souring of public opinion toward CEO Elon Musk fuels worries of lower sales.

image for news Tesla's stock falls again, and this analyst says why it's an Elon Musk problem

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Huntington Ingalls Industries, Inc. ("Huntington Ingalls" or "the Company") (NYSE:HII). Investors who purchased Huntington Ingalls securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HII.

image for news Huntington Ingalls Industries, Inc. (HII) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.

image for news Vicor Corporation (VICR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lamb Weston Holdings, Inc. ("Lamb Weston" or "the Company") (NYSE:LW). Investors who purchased Lamb Weston securities prior to July 25, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LW.

image for news Bronstein, Gewirtz & Grossman, LLC Encourages Lamb Weston Holdings, Inc. (LW) Stockholders to Inquire about Securities Investigation

KIDZ BOP AND LIVE NATION ANNOUNCE "KIDZ BOP LIVE Certified BOP Tour" — Neutral

LYV   PRNewsWire — February 10, 2025

All-New KIDZ BOP LIVE Show Hitting 60+ Cities in 2025 Setlist Includes Hits From KIDZ BOP's Latest Album, 'KIDZ BOP 50' Ticket Presales Begin February 11; General On-Sale Starts February 14 NEW YORK , Feb. 10, 2025 /PRNewswire/ -- KIDZ BOP , the #1 music brand for kids, and Live Nation announce brand-new KIDZ BOP LIVE Certified BOP Tour . The ultimate pop concert for kids is back for 2025, kicking off on June 14 in Stamford, CT before hitting 60+ more cities, including Atlanta, Boston, Houston and New York.

image for news KIDZ BOP AND LIVE NATION ANNOUNCE "KIDZ BOP LIVE Certified BOP Tour"

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LUNA.

image for news Bronstein, Gewirtz & Grossman, LLC Encourages Luna Innovations Incorporated (LUNA) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of New Fortress Energy Inc. ("New Fortress" or "the Company") (NASDAQ:NFE). Investors who purchased New Fortress securities prior to December 2, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NFE.

image for news Bronstein, Gewirtz & Grossman, LLC Is Investigating New Fortress Energy Inc. (NFE) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. ("Innodata" or "the Company") (NASDAQ:INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INOD.

image for news Bronstein, Gewirtz & Grossman, LLC Encourages Innodata Inc. (INOD) Stockholders to Inquire about Securities Investigation

Washington, D.C.--(Newsfile Corp. - February 10, 2025) - The US-India Strategic Partnership Forum (USISPF) is delighted to welcome Mr.

image for news Jack P. Williams, Senior Vice President, ExxonMobil, Joins the USISPF Board of Directors

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Malibu Boats, Inc. ("Malibu Boats" or "the Company") (NASDAQ:MBUU). Investors who purchased Malibu Boats securities prior to November 4, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MBUU.

image for news Bronstein, Gewirtz & Grossman, LLC Encourages Malibu Boats, Inc. (MBUU) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.

image for news Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teradata Corporation ("Teradata" or "the Company") (NYSE:TDC). Investors who purchased Teradata securities prior to February 13, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TDC.

image for news Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teradata Corporation (TDC) and Encourages Investors to Learn More About the Investigation

MILWAUKEE , Feb. 10, 2025 /PRNewswire/ -- Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, has been named a top thermal management provider for data centers by ABI Research. The recognition highlights Johnson Controls' excellence in innovation and implementation, driven by its comprehensive product portfolio, global presence, and customer-centric approach to the data center thermal management industry.

image for news Johnson Controls Named Leading Thermal Management Provider for Data Centers by ABI Research

First Cohort B patient received 4 doses (approx. 819 million Gamma Delta T-cells) Cohort B recruitment continues at multiple clinical sites across the United Kingdom EDINBURGH, Scotland , Feb. 10, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced the first Cohort B patient in the ACHIEVE Phase 2B UK clinical trial, evaluating TCB008 in Acute Myeloid Leukemia, has completed the full dosing regiment.

image for news TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial